IL10 and hepatocellular carcinoma: It has been reported that there is a new population of CD14+CTLA-4+ regulatory DCs in the PBMCs of HCC patients that suppressed T-cell response via CTLA-4-dependent IL-10 and IDO production.15 However, how CD14+CTLA-4+ DCs are induced remains unknown.